Gregory J. Dore
Elite in Hepatitis C

Gregory J. Dore

St Vincent's Hospital
Darlinghurst, NSW, AU 
Elite in Hepatitis C
St Vincent's Hospital
Darlinghurst, NSW, AU 
OverviewLocationsClinical Research

Overview

Gregory Dore practices in Darlinghurst, Australia. Mr. Dore is rated as an Elite expert by MediFind in the treatment of Hepatitis C. His top areas of expertise are Hepatitis C, Hepatitis, Hepatitis B, HIV/AIDS, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 412 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 352 articles and participated in 2 clinical trials in the study of Hepatitis C.

Gender
Male

Locations

St Vincent's Hospital
Darlinghurst, NSW, Australia
Other Locations
UNSW Sydney, High St, Kensington, NSW 2052, Australia
High St, Kensington, NSW 2052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label, Multicentre, International Pilot Study of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir With or Without Ribavirin or Glecaprevir/Pibrentasvir for People With Recently Acquired Hepatitis C Virus Infection With or Without HIV Co-infection.
An Open Label, Multicentre, International Pilot Study of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir With or Without Ribavirin or Glecaprevir/Pibrentasvir for People With Recently Acquired Hepatitis C Virus Infection With or Without HIV Co-infection.
Enrollment Status: Completed
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drugs: Paritaprevir+Ritonavir+Ombitasvir, Dasabuvir, Ribavirin, Glecaprevir+Pibrentasvir
Study Phase: Phase 3
A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
Enrollment Status: Completed
Publish Date: February 27, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

412 Total Publications

Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia.
Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia.
Journal: Emerging infectious diseases
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dore's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile